In Conversation With Scientist and CRISPR Pioneer Jennifer Doudna
Posted by btwatson on January 27, 2018 10:07 pm
Tags:
Categories:
Crispr
In Conversation With Scientist and CRISPR Pioneer Jennifer Doudna
Join Susan MacTavish Best in discussion with Jennifer Doudna. You’ll hear about gene editing and how the technology surrounding it has evolved.
Crispr News
-
Crispr Genomic Cure Market: Moving Towards a Brighter Future | An ... - Digital JournalOctober 3, 2023
-
Regeneron and Intellia Announce Expanded Research ... - Bluefield Daily TelegraphOctober 3, 2023
-
Repare Therapeutics to Host Conference Call and Webcast to ... - InvestorsObserverOctober 3, 2023
-
Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately ... - The Motley FoolOctober 3, 2023
-
Genome Engineering Market Research Report With Qualitative and ... - Digital JournalOctober 3, 2023
-
Sharper and Smaller – Tiny CRISPR Tool Could Help Shred Viruses - SciTechDailyOctober 3, 2023
-
Emerging Players and Innovative Technologies Transform the Landscape of Allogeneic CAR Cell Therapy Market - Yahoo FinanceOctober 2, 2023
-
5 FDA decisions to watch in the fourth quarter - BioPharma DiveOctober 2, 2023
-
Art imitates science - ASBMB TodayOctober 2, 2023
-
Better Gene Editing Stock: Editas Medicine vs. CRISPR Therapeutics - NasdaqOctober 2, 2023
-
Better Gene Editing Stock: Editas Medicine vs. CRISPR Therapeutics - The Motley FoolOctober 2, 2023
-
Readout Newsletter: Biotech news, J&J TB drug, Nobel winners - STATOctober 2, 2023
-
Rare mutation may counteract “Alzheimer’s gene” - FreethinkOctober 2, 2023
-
What we heard at World Agri-Tech and Future Food-Tech in London - AgFunderNewsOctober 2, 2023
-
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation - The Motley FoolOctober 2, 2023
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.